Australia markets close in 3 hours 47 minutes

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
46.71+1.04 (+2.28%)
At close: 04:00PM EDT
46.71 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3332
Avg. Estimate3.361.8910.764.4
Low estimate2.951.4810.073.59
High estimate3.832.4811.65.21
Year ago EPS0.930.562.5910.76
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate116.89M86.79M401M287.85M
Low estimate107.46M76.6M398.8M265.2M
High estimate134.4M94.9M405.4M319.94M
Year ago salesN/A46.4M171.55M401M
Sales growth (year/est)N/A87.00%133.80%-28.20%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS0.80.830.943.88
Actual EPS0.930.560.854.04
Difference0.13-0.27-0.090.16
Surprise %16.20%-32.50%-9.60%4.10%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate3.361.8910.764.4
7 days ago3.491.8410.624.68
30 days ago3.631.9510.864.8
60 days ago3.63210.974.8
90 days ago2.11.697.354.35
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 days1N/A1N/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A111
Growth estimatesEGRXIndustrySector(s)S&P 500
Current qtr.261.30%N/AN/AN/A
Next qtr.237.50%N/AN/AN/A
Current year315.40%N/AN/AN/A
Next year-59.10%N/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)16.79%N/AN/AN/A